Latest News - DexCom
Top Corporates Hub
DexCom
Is DexCom (DXCM) Fairly Priced After Recent Share Price Weakness?
03.04.2026 01:16
If you are wondering whether DexCom's current share price lines up with its underlying worth, or if the market is mispricing the stock, this article walks through that question step by step. DexCom recently closed at US$62.22, with returns of 5.9% decline over 7 days, 14.9% decline over 30 days, 6.5% decline year to date, 0.7% over 1 year, 44.7% decline over 3 years and 34.2% decline over 5 years. These moves can signal shifting views on both opportunity and risk. These mixed returns have...
American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA
01.04.2026 12:30
CRO to Incorporate DEXCOM's Continuous Glucose Monitoring "CGM" Technology In the GlucoGuard Multi Patient StudyDel Mar, California--(Newsfile Corp. - April 1, 2026) - American Diversified Holdings Corporation (OTCID: ADHC) announce today that GlucoGuard has retained a internationally recognized Contract Research Organization (CRO) to begin its patient studies to establish safety and efficacy concerns as required by the FDA. The Scope of Work agreement will comply with the FDA's requests to...
Diabetes Focused MiniMed Recovery Story Builds As Pipeline Improves
01.04.2026 10:15
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising competition and past share losses.
DexCom Inc (NASDAQ:DXCM) Presents a Growth Stock Breakout Opportunity
25.03.2026 11:51
DexCom (DXCM) combines strong growth fundamentals with a technical breakout setup, offering a potential entry point for investors.
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
23.03.2026 10:39
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 1.1% gain over the past six months while the S&P 500 was stuck in neutral.
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know
17.03.2026 01:32
A number of stocks jumped in the afternoon session after easing crude oil prices helped lift investor sentiment and reduce inflation worries.
This Internet Infrastructure Stock Plunged 72% in a Year, so Why Did an Investor Buy Up $12 Million?
15.03.2026 15:01
Cogent Communications delivers high-speed internet and data center services to commercial clients across multiple continents.
Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals
15.03.2026 14:50
Sotera Health delivers sterilization and lab testing services to regulated industries worldwide, supporting critical supply chains.
Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a Farm & more
13.03.2026 12:39
These are some of the stocks posting the largest moves midday.
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
11.03.2026 06:00
BARCELONA, Spain, March 11, 2026--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more details about future product features across its global portfolio at the upcoming 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona, March 11-14, 2026.
DexCom Inc (NASDAQ:DXCM): A Prime Example of Growth at a Reasonable Price
10.03.2026 10:11
DexCom (DXCM) exemplifies the GARP strategy, offering strong, sustained growth at a valuation reasonable for its sector, backed by robust profitability and financial health.
Is DexCom Stock Underperforming the Nasdaq?
05.03.2026 13:41
DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s future.
Dexcom Appoints Rick Osterloh to Board of Directors
26.02.2026 21:15
SAN DIEGO, February 26, 2026--Dexcom Appoints Rick Osterloh to Board of Directors
Aristotle Growth Equity Fund Bets on DexCom (DXCM) Due to Its Expanding CGM Market Leadership
26.02.2026 13:03
Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time highs in Q4 2025, with the S&P 500 Index rising 2.66% and the Bloomberg U.S. Aggregate Bond Index increasing by 1.10%. Within the Russell 1000 Growth Index, […]
DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals
26.02.2026 02:13
DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring systems among patients using GLP-1 drugs, as physicians pair both therapies for diabetes care. The company is refining its product lineup, with management expecting the 15 day G7 CGM system to take a leading role within its portfolio. These developments are material for investors because they relate to DexCom's growth paths across domestic and international CGM markets beyond standard earnings...
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
25.02.2026 14:35
It's another reason to invest in this exciting medical device stock.
Dexcom Announces Upcoming Conference Presentation
25.02.2026 13:30
SAN DIEGO, February 25, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026.
BTIG Reiterates Buy on DexCom, Maintains $85 Price Target
25.02.2026 06:39
BTIG analyst Marie Thibault reiterates DexCom (NASDAQ:DXCM) with a Buy and maintains $85 price target.
Mizuho Raises DexCom (DXCM) Price Target to $90 from $78 After Earnings Beat
25.02.2026 02:29
We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst Anthony Petrone raised the price target on DexCom, Inc. (NASDAQ:DXCM) to $90 from $78 while maintaining an Outperform rating, citing a favorable post-earnings setup following a quarterly beat that exceeded expectations. The previous day, […]
Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story?
23.02.2026 12:08
In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 million for the year, and reaffirmed its 2026 revenue guidance of US$5.16–US$5.25 billion. The company also completed a US$499.99 million share repurchase program and highlighted strong uptake of its 15-day G7 sensor, underscoring management’s confidence in product adoption and capital...